Adding value through innovation

Our Discovery Programs are designed and executed with the purpose of partnering with pharma discovery biotech companies. Details of Aurigene's programs can be shared under a confidentiality agreement and appropriate expression of intent.

Aurigene projects are aimed at development of novel drugs for treating Metabolic disorders, Oncology and inflammation. The competitive advantage of Aurigene's integrated SBDD approach is the ability to deliver leads cost-effectively and at much shorter timelines as compared to other conventional methods.

Programs for early partnerships